MedPath

Numab Therapeutics AG

Numab Therapeutics AG logo
🇨🇭Switzerland
Ownership
Holding
Established
2011-01-01
Employees
51
Market Cap
-
Website
http://www.numab.com

NM32-2668 in Adult Patients With Selected Advanced Solid Tumors

Phase 1
Active, not recruiting
Conditions
Triple Negative Breast Cancer
Ovarian Carcinoma
Leiomyosarcoma
Adenocarcinoma - Gastroesophageal Junction (GEJ)
Endometrial Cancer
Peritoneal Carcinoma
Mesothelioma, Malignant
Adenocarcinoma of the Stomach
Melanoma, Malignant
Renal Cell Carcinoma
Interventions
First Posted Date
2024-03-07
Last Posted Date
2025-05-21
Lead Sponsor
Numab Therapeutics AG
Target Recruit Count
180
Registration Number
NCT06299163
Locations
🇺🇸

Medical University of South Carolina (MUSC), Charleston, South Carolina, United States

🇺🇸

The University of Chicago Medical Center (UCMC), Chicago, Illinois, United States

🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

and more 8 locations

Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)

Phase 1
Terminated
Conditions
Atopic Dermatitis
Interventions
Other: Placebo
First Posted Date
2023-05-16
Last Posted Date
2025-04-03
Lead Sponsor
Yellow Jersey Therapeutics AG
Target Recruit Count
126
Registration Number
NCT05859724
Locations
🇺🇸

First OC Dermatology Research, Fountain Valley, California, United States

🇺🇸

California Clinical Trials Medical Group (CCTMG) managed by Parexel, Glendale, California, United States

🇺🇸

TCR Medical Corporation, San Diego, California, United States

and more 12 locations

A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors

Phase 1
Terminated
Conditions
Ovarian Carcinoma
Head and Neck Squamous Cell Carcinoma
Triple Negative Breast Cancer
Advanced Solid Tumor
Colorectal Cancer
Fallopian Tube Cancer
Non-small Cell Lung Cancer
Squamous Cell Carcinoma
Peritoneal Carcinoma
Interventions
Biological: NM21-1480
First Posted Date
2020-06-22
Last Posted Date
2024-02-28
Lead Sponsor
Numab Therapeutics AG
Target Recruit Count
52
Registration Number
NCT04442126
Locations
🇺🇸

The University Of Texas MD Anderson Cancer Center, Houston, Texas, United States

🇺🇸

Virginia Cancer Specialists, Fairfax, Virginia, United States

🇺🇸

Augusta University Medical Center, Augusta, Georgia, United States

and more 23 locations
© Copyright 2025. All Rights Reserved by MedPath